Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Noam Auslander(National Institutes of Health), Eytan Ruppin(Cedars-Sinai Medical Center), Ryan J. Sullivan(Dana-Farber Cancer Institute), Genevieve M. Boland(Harvard University), Keith T. Flaherty(Cancer Research Center), Meenhard Herlyn(The Wistar Institute), Sanna Madan(National Institutes of Health), Joo Sang Lee(National Institutes of Health), Dennie T. Frederick(Broad Institute), Gao Zhang(Central South University), Tabea Moll(Johns Hopkins University), Zhi Wei(New Jersey Institute of Technology), Benchun Miao(Massachusetts General Hospital), Tian Tian(Nanjing University)
Cited by 813
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k